FDA Studies New Strategies for Presentation of Patient Information

Abstract

Get full access to this article

View all access options for this article.

References

Kimberlin

Winterstein

. Expert and consumer evaluation of consumer medication information—2008. http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ReportsBudgets/UCM163783.pdf. Published November 4, 2008.

Aker

Beck

Papay

. Consumers better understand and prefer simplified written drug information: an evaluation of 2 novel formats versus the current CMI. Therapeutic Innovation & Regulatory Science. 2013;47(1):125–132.

Bui

Nakamura

Bray

Zeng-Treitler

. Automated illustration of patients instructions. AMIA Annu Symp Proc. 2012;2012:1158–1167.

Chan

. Effects of prospective-user factors and sign design features on guessability of pharmaceutical pictograms. Patient Educ Couns. 2013;90(2):268–275.

Dowse

Ramela

Barford

Browne

. Developing visual images for communicating information about antiretroviral side effects to a low-literate population. Afr J AIDS Res. 2010;9(3):213–224.

Kassam

Vaillancourt

Collins

. Pictographic instructions for medications: do different cultures interpret them accurately? Int J Pharm Pract. 2004;12(4):199–209.

Raynor

Dickinson

. Key principles to guide development of consumer medicine information—content analysis of information design texts. Ann Pharmacother. 2009;43(4):700–706.

Shrank

Avorn

Rolon

Shekelle

. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783–801.

Wilson

Wolf

. Working memory and the design of health materials: a cognitive factors perspective. Patient Educ Couns. 2009;74(3):318–322.

10.

Wolf

Davis

Bass

. Improving prescription drug warnings to promote patient comprehension. Arch Int Med. 2010;170(1):50–56.